Molecular basis of mucopolysaccharidosis IVA in a large cohort: genotype–phenotype correlations and reporting of 12 novel GALNS variants
Human Molecular Genetics · 2026
DOI: 10.1093/hmg/ddag101 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2026. Verfasst von Xi Yin und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, No.9 Jinsui Road, Guangzhou 51…. Hauptthemen laut MEDLINE: Mucopolysaccharidosis IV, Chondroitinsulfatases. Die Arbeit nennt 45 Literaturangaben. Gefördert von: Guangzhou Municipal Science and Technology Project.
Abstract (Originalsprache)
Mucopolysaccharidosis type IVA (MPS IVA) is an autosomal recessive lysosomal storage disorder caused by deficient activity of N-acetylgalactosamine-6-sulfatase (GALNS). In this single-center study, we analyzed the clinical and genetic characteristics of 82 pediatric MPS IVA patients, including 68 severe, 12 intermediate, and 2 mild cases. The most common clinical manifestations were pectus carinatum (72%), short stature (56%), and genu valgum (45%). All patients showed markedly reduced GALNS activity, although no significant difference was observed across phenotypic subgroups. Genetic analysis identified 66 distinct GALNS variants, 12 of which were novel. The c.953T>G (p.M318R) variant was the most frequent allele (24.7%). Based on integrated clinical, structural, and in silico assessments, p.M318R and p.R386C were linked to severe disease, whereas p.P499L was associated with mild phenotypes. Protein structure analysis revealed that all homozygous missense variants located in domain 1 correlated with severe presentations. Among patients carrying two missense variants, 85% (34/40) exhibited severe symptoms, and 70.6% (24/34) of these had at least one variant affecting buried residues. Notably, 85.7% (24/28) of patients with biallelic buried-residue missense variants were classified as severe. In summary, this study delineates the phenotypic spectrum of MPS IVA, expands its genotypic landscape, and provides a foundation for further genotype–phenotype investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Endocrinology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, No.9 Jinsui Road, Guangzhou 510623, China.
ORCID-Profile: Xueying Su
Förderung
- Guangzhou Municipal Science and Technology Project
Zitieren
APA
Yin, X., Qin, Y., Su, X., Deng, Q., Li, C., Zhao, X., Zeng, C., Liang, C., Cai, Y., Shao, Y., Huang, Y., Liu, L., & Zhang, W. (2026). Molecular basis of mucopolysaccharidosis IVA in a large cohort: genotype–phenotype correlations and reporting of 12 novel GALNS variants. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddag101
Vancouver
Yin X, Qin Y, Su X, Deng Q, Li C, Zhao X, et al. Molecular basis of mucopolysaccharidosis IVA in a large cohort: genotype–phenotype correlations and reporting of 12 novel GALNS variants. Human Molecular Genetics. 2026. doi:10.1093/hmg/ddag101
BibTeX
@article{Yin2026,
author = {Yin, Xi and Qin, Yiqi and Su, Xueying and Deng, Qianqian and Li, Chengxi and Zhao, Xiaoyuan and Zeng, Chunhua and Liang, Cuili and Cai, Yanna and Shao, Yongxian and Huang, Yonglan and Liu, Li and Zhang, Wen},
title = {Molecular basis of mucopolysaccharidosis IVA in a large cohort: genotype–phenotype correlations and reporting of 12 novel GALNS variants},
journal = {Human Molecular Genetics},
year = {2026},
doi = {10.1093/hmg/ddag101}
}
EUVIMED